Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs
2/28/2014 7:25:24 AM
More...
|
Bayer AG (BAYN.DE) Buys Dihon Pharmaceutical Group For About $680 Million To Add Traditional Chinese Medicine To Product Line
2/27/2014 7:48:49 AM
More...
|
Bayer AG (BAYN.DE) Clinches $2.9 Billion Deal For Norway's Algeta
2/24/2014 7:14:33 AM
More...
|
Bayer AG (BAYN.DE) Initiates Phase 3 Trial Of Stivarga® (Regorafenib) Tablets In Patients With Colorectal Cancer After Resection Of Liver Metastases
2/20/2014 9:40:35 AM
More...
|
FDA Rejects Wider Use Of Bayer AG (BAYN.DE)'s Xarelto Drug For Acute Coronary Syndrome
2/14/2014 7:03:39 AM
More...
|
Bayer AG (BAYN.DE) Forms Translational Drug Discovery Collaboration With Peking University
1/9/2014 12:29:53 PM
More...
|
German Watchdog Deals Setback To Bayer AG (BAYN.DE) Eye Drug Eylea
1/3/2014 7:11:07 AM
More...
|
Bayer AG (BAYN.DE) Bets On One-Of-A-Kind Formula To Spark Innovation
1/2/2014 8:07:43 AM
More...
|
Bayer AG (BAYN.DE) Secures Cancer Firm Algeta With Raised $2.9 Billion Bid
12/19/2013 6:27:51 AM
More...
|
Bayer AG (BAYN.DE), Eli Lilly and Company (LLY) Skim Over Novartis AG (NVS)'s Animal Health Books
12/3/2013 7:14:07 AM
More...
|
|